中欧医疗健康混合C(003096)利润分配表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
收入 |
2,673,692,328.83 |
-6,832,715,619.47 |
-9,353,497,803.84 |
-11,862,222,230.61 |
利息合计 |
3,150,957.26 |
6,620,784.87 |
3,360,646.17 |
34,825,696.08 |
其中:存款利息收入 |
3,150,957.26 |
5,843,675.04 |
2,583,536.34 |
11,250,421.83 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
777,109.83 |
777,109.83 |
23,575,274.25 |
投资收益合计 |
-5,421,479,243.52 |
-9,206,803,260.58 |
-5,279,354,112.93 |
-9,617,538,262.04 |
其中:股票投资收益 |
-5,644,285,881.50 |
-9,873,683,414.88 |
-5,692,074,223.37 |
-10,140,802,298.00 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
8,256,654.93 |
11,640,667.28 |
9,887,612.89 |
22,040,506.82 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
214,549,983.05 |
655,239,487.02 |
402,832,497.55 |
501,223,529.14 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
8,085,647,867.29 |
2,350,183,522.18 |
-4,084,452,077.81 |
-2,319,244,546.59 |
其他收入 |
6,372,747.80 |
17,283,334.06 |
6,947,740.73 |
39,734,881.94 |
费用 |
274,682,166.91 |
643,905,809.66 |
342,962,941.09 |
1,121,243,442.47 |
管理人报酬 |
183,126,838.67 |
426,942,336.85 |
227,035,474.81 |
759,784,934.75 |
基金托管费 |
30,521,139.76 |
71,157,056.20 |
37,839,245.82 |
126,630,822.49 |
销售服务费 |
60,916,881.56 |
145,570,007.44 |
77,940,556.80 |
234,529,083.38 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
117,267.43 |
236,393.66 |
147,663.66 |
298,592.44 |
利润总额 |
2,399,010,161.92 |
-7,476,621,429.13 |
-9,696,460,744.93 |
-12,983,465,673.08 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年